الرسائل الموجهة للمختصين الصحيين

Risk of serious birth defects when administered during pregnancy<strong> </strong><strong>​</strong>

Recommendations to avoid potentially fatal dosing errors when using methotrexate “METHOTREXATE &amp;quot;EBEWE “ for autoimmune diseases

Roaccutne (isotretinoin): An update on neuropsychiatric disorders.

(lixisenatide /insuline glargin):&nbsp; Important information on dosing.

Gilenya (fingolimod)): New contraindication in pregnant women and in women of childbearing potential not using effective contraception.

Advaquin ( levofloxacin): Risk of aortic aneurysm and dissection.

Darzalex (Daratumumab): New identified risk of hepatitis B reactivation.

Alemtuzumab (Lemtrada): New safety information.

Direct Healthcare Professional Communication (DHPC) for the Direct Oral Anticoagulants (DOACs) Apixaban, Edoxaban, Dabigatran and Rivaroxaban.

Blincyto (pembrolizumab):&nbsp;Risk of Medication Errors and Benzyl alcohol toxicity​.